Table 1. RIFLE and AKIN classification schemes for AKI .
| GFR criteria | Urine output criteria | ||
| RIFLE: an acute rise of SCr over 7 days | |||
| Risk | Increase in SCr ≥ 1.5 × baseline or decrease in GFR ≥ 25% | UO < 0.5 ml/kg/h × 6 h | |
| Injury | Increase in SCr ≥ 2.0 × baseline or decrease in GFR ≥ 50% | UO < 0.5 ml/kg/h × 12 h | |
| Failure | Increase in SCr ≥ 3.0 × baseline or SCr ≥ 4.0 mg/dl (354 μmol/l) or decrease in GFR ≥ 75% | UO < 0.3 ml/kg/h × 24 h or anuria × 12 h | |
| Loss | Complete loss of kidney function > 4 weeks | ||
| ESKD | End stage renal disease (> 3 months) | ||
| AKIN: an acute rise of SCr within 48 h | |||
| Stage 1 | Same as RIFLE-Risk plus increase in SCr ≥ 0.3 mg/dl (≥ 26.4 μmol/l) | Same as RIFLE | |
| Stage 2 | Same as RIFLE-Injury | ||
| Stage 3 | Same as RIFLE-Failure plus initiation of RRT |
AKIN, acute kidney injury network; ESKD, end-stage kidney disease; GFR, glomerular filtration rate; RIFLE, risk of renal failure, injury to the kidney, failure of kidney function, loss of kidney function, and end-stage renal failure; RRT, renal replacement therapy; SCr, serum creatinine; UO, urine output.